Strategic Growth Opportunities in the Mesenchymal Stem Cell and Exosome Diagnostics and Therapies Market
The regenerative medicine industry is experiencing significant transformation as cell-based and exosome-based therapies offer new hope for patients with chronic and degenerative diseases. The Mesenchymal Stem Cell and Exosome Diagnostics and Therapies Market is valued at USD 6.6 billion in 2025 and projected to reach USD 15 billion by 2035 at a CAGR of 8.6%. This article explores...
0 Commentarios 0 Acciones 4 Views 0 Vista previa